Mesoblast Limited; Non-healing Bones Repaired In Clinical Trial Using Adult Stem Cells

This article was originally published here

Melbourne, Aug 6, 2008 (ABN Newswire) – The Royal Melbourne Hospital and Australia’s regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), today jointly announced successful results from the long bone fracture repair clinical trial using Mesoblast’s proprietary adult stem cell technology.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply